Ionis Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $97.43, Implies 15% Upside

• According to estimates from 21 analysts, Ionis Pharmaceuticals, Inc. stock's average price target has fallen from $99.38 to $97.43, with forecasts ranging from $68 to $130 per share
• Based on the Jul. 8 closing price, the updated target implies approximately 15% potential upside
• Consensus rating remains at “Buy” across 26 covering analysts, with 22 Buys, 4 Holds and 0 Sells

Explore more price target data and ratings for Ionis Pharmaceuticals, Inc. on the , and track all previous and future analyst recommendations for Ionis Pharmaceuticals, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.